Literature DB >> 21967512

High prevalence of subclinical rheumatic heart disease in pregnant women in a developing country: an echocardiographic study.

Håvard Otto1, Sverre Georg Saether, Leul Banteyrga, Bjørn Olav Haugen, Terje Skjaerpe.   

Abstract

OBJECTIVES: Pregnant women with rheumatic heart disease (RHD) carry a high risk of morbidity and mortality. In this study the prevalence of subclinical RHD in pregnant women in Keren, Eritrea was assessed using echocardiography. METHODS AND
RESULTS: A prospective cross sectional survey of pregnant women attending a midwife consultation was carried out by two specially trained medical students and an experienced cardiologist. The women were screened by the medical students using echocardiography. All recordings were reviewed and evaluated by the experienced cardiologist before a final diagnosis was given. Eight of the 348 screened women had definite RHD. This corresponds to a prevalence of 2.3%, 95% CI (0.7-3.9).
CONCLUSION: 2.3% of the pregnant women in Keren were found to have subclinical RHD.
© 2011, Wiley Periodicals, Inc.

Entities:  

Mesh:

Year:  2011        PMID: 21967512     DOI: 10.1111/j.1540-8175.2011.01520.x

Source DB:  PubMed          Journal:  Echocardiography        ISSN: 0742-2822            Impact factor:   1.724


  13 in total

1.  Non-communicable diseases during pregnancy in low and middle income countries.

Authors:  Julia Hussein
Journal:  Obstet Med       Date:  2016-12-23

Review 2.  Echocardiographic screening for subclinical rheumatic heart disease remains a research tool pending studies of impact on prognosis.

Authors:  Liesl Zühlke; Bongani M Mayosi
Journal:  Curr Cardiol Rep       Date:  2013-03       Impact factor: 2.931

Review 3.  Position statement of the World Heart Federation on the prevention and control of rheumatic heart disease.

Authors:  Bo Remenyi; Jonathan Carapetis; Rosemary Wyber; Kathryn Taubert; Bongani M Mayosi
Journal:  Nat Rev Cardiol       Date:  2013-04-02       Impact factor: 32.419

Review 4.  Cardiovascular disease in Africa: epidemiological profile and challenges.

Authors:  Ashley K Keates; Ana O Mocumbi; Mpiko Ntsekhe; Karen Sliwa; Simon Stewart
Journal:  Nat Rev Cardiol       Date:  2017-02-23       Impact factor: 32.419

5.  The role of causal knowledge in stigma considerations in African genomics research: Views of South African Xhosa people.

Authors:  Olivia P Matshabane; Megan M Campbell; Marlyn C Faure; Paul S Appelbaum; Patricia A Marshall; Dan J Stein; Jantina de Vries
Journal:  Soc Sci Med       Date:  2021-04-07       Impact factor: 5.379

6.  The natural history of latent rheumatic heart disease in a 5 year follow-up study: a prospective observational study.

Authors:  Liesl Zühlke; Mark E Engel; Carolina E Lemmer; Marnie van de Wall; Simpiwe Nkepu; Alet Meiring; Michael Bestawros; Bongani M Mayosi
Journal:  BMC Cardiovasc Disord       Date:  2016-02-19       Impact factor: 2.298

Review 7.  Group A Streptococcus, Acute Rheumatic Fever and Rheumatic Heart Disease: Epidemiology and Clinical Considerations.

Authors:  Liesl J Zühlke; Andrea Beaton; Mark E Engel; Christopher T Hugo-Hamman; Ganesan Karthikeyan; Judith M Katzenellenbogen; Ntobeko Ntusi; Anna P Ralph; Anita Saxena; Pierre R Smeesters; David Watkins; Peter Zilla; Jonathan Carapetis
Journal:  Curr Treat Options Cardiovasc Med       Date:  2017-02

Review 8.  Surgery for rheumatic mitral valve disease in sub-saharan African countries: why valve repair is still the best surgical option.

Authors:  Charles Mve Mvondo; Marta Pugliese; Alessandro Giamberti; David Chelo; Liliane Mfeukeu Kuate; Jerome Boombhi; Ellen Marie Dailor
Journal:  Pan Afr Med J       Date:  2016-08-11

Review 9.  Rheumatic heart disease: infectious disease origin, chronic care approach.

Authors:  Judith M Katzenellenbogen; Anna P Ralph; Rosemary Wyber; Jonathan R Carapetis
Journal:  BMC Health Serv Res       Date:  2017-11-29       Impact factor: 2.655

Review 10.  Congenital heart disease and rheumatic heart disease in Africa: recent advances and current priorities.

Authors:  Liesl Zühlke; Mariana Mirabel; Eloi Marijon
Journal:  Heart       Date:  2013-05-16       Impact factor: 5.994

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.